CD8A and cancer: To verify whether pH1047L could be endogenously presented by HLA-A*11:01 positive target cells, we examined the TCR-T cell, generated from primary CD8+ T cells, response to various cancer cell lines expressing PIK3CAH1047L and HLA-A*11:01.